NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Prophylaxis of pertussis, diphtheria, tetanus, and poliomyelitis infection.
Date of first enrollment	17/11/2010
Target sample size	374
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : DD-687 INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Subcutaneous injection control material(s) Generic name etc : DTaP, Oral Polio Vaccine INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Subcutaneous injection, Oral

Outcome(s)

Primary Outcome	Immunogenicity anti-Polio 1, 2 and 3 antibody titers
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	Not applicable
Age maximum	Not applicable
Gender	Both
Include criteria	starting at 3-68 (recommended 3-8) months of age
Exclude criteria